MARLEE PONDER: Open Payments
NPI 1265031637 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$589 in 34 payments from 11 companies in 2025. Trend: 2023 $41 · 2024 $184 · 2025 $589
Food & beverage: $589
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $175 |
| Gilead Sciences, Inc. | 5 | $97 |
| Lilly USA, LLC | 5 | $76 |
| Phathom Pharmaceuticals, Inc. | 4 | $54 |
| Dexcom, Inc. | 2 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $29 |
| PFIZER INC. | 1 | $27 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
| Novo Nordisk Inc | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: VRAYLAR, MOUNJARO, VOQUEZNA, Dexcom G6 Transmitter, CAPLYTA, PREVNAR 20, TZIELD, UBRELVY.
Industry payments across KY — which companies pay providers there.
